Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
May 08, 2026
Everpure (PSTG): Navigating Volatility with Strong AI-Driven Growth and a $90+ Price Target

Everpure (PSTG): Navigating Volatility with Strong AI-Driven Growth and a $90+ Price Target

Key Takeaways

  • Everpure, formerly Pure Storage, achieved its first billion-dollar revenue quarter in Q4 FY2026 at $1.06B, up 20% YoY, with EPS of $0.69 beating estimates.
  • Rebranded to Everpure in February 2026 alongside intent to acquire 1touch for enhanced data intelligence, signaling pivot to comprehensive data management.
  • Analyst consensus remains "Moderate Buy" with average price target around $90-$93, implying 20-25% upside from recent levels near $74.
  • Stock traded volatilely in recent weeks amid insider sales and component cost concerns, but AI-driven demand supports subscription growth.
  • Q1 FY2027 earnings expected late May, with guidance for strong hyperscale and enterprise AI infrastructure expansion.

Current Market Snapshot

I've been keeping a close eye on Everpure (PSTG) shares lately, as they've moved through some volatility in recent sessions. This mirrors the broader tech sector's swings, driven by AI enthusiasm and macroeconomic caution. With a market cap around $24.6 billion, the stock sits within its 52-week range of roughly $48 to $101. What stands out is the demand for its all-flash storage solutions, which are essential for data-intensive AI workloads. In recent weeks, we've seen upward momentum from analyst notes on accelerating bookings, offset somewhat by insider selling and concerns over rising component costs impacting margins. Trading volume has stayed elevated, reflecting strong investor interest in the company's shift toward a full data platform amid enterprise modernization. Overall, the sentiment feels constructive to me, particularly with subscription services annual recurring revenue (ARR) growth topping 15%.

Recent Developments Driving the Price Action

From what I see, PSTG's price action in recent weeks stems from a blend of solid fundamentals, strategic moves, and some headwinds. The key event was on February 23, 2026, when Everpure—formerly Pure Storage—unveiled its rebrand and a definitive agreement to acquire 1touch, a data intelligence firm. This acquisition is set to strengthen the Enterprise Data Cloud platform with better discovery, classification, and orchestration capabilities, moving the company beyond hardware into AI-ready data management. Shares dipped initially on rebrand uncertainty but bounced back strongly after the Q4 FY2026 earnings release on February 25.

Those results were a milestone: revenue reached $1.06 billion, up 20% year-over-year and marking the first $1B quarter, beating estimates of $1.03B. Non-GAAP EPS came in at $0.69, topping the $0.64 consensus. Product revenue jumped 25% to $618M, fueled by AI infrastructure demand, while subscription services rose 14% to $440M, pushing ARR close to $1.9B. Non-GAAP operating margin improved to 21.3% ($226M), and remaining performance obligations (RPO) rose sharply, indicating a strong backlog. The stock gained 8.6% after hours, driven by optimism around hyperscale deals and modernization trends.

Analysts reacted positively overall: Piper Sandler maintained Overweight with a $92 target, highlighting cloud deal execution; Northland upgraded to Outperform at $81, pointing to 39% bookings growth. The consensus target of around $90-$93 suggests 20%+ upside. That said, Wells Fargo cut its target to $90 from $100 due to component cost inflation pressuring margins, which contributed to some pullbacks. Insider sales have added caution too—Chief Visionary Officer John Colgrove sold shares worth about $12M in late April, with more activity noted recently, which is common for executives but still noteworthy.

Earlier catalysts included enhancements to the partner program on February 4, focusing on a 100% channel go-to-market model with a new "Ambassador" tier and specializations in AI, cyber resilience, and cloud. A pricing increase on March 25 also supports the revenue path. No big partnerships or products in the last 30 days, but ongoing AI integrations—like those with Nvidia and Nutanix—continue to support sentiment. Macro tailwinds from hyperscaler AI capex have helped, though broader tech rotation has weighed in. The price has stabilized near $70-$76 on daily volume of about 3-4M shares, with Q1 FY2027 earnings due late May as the next big focus, alongside upbeat FY2027 guidance for $3.63-3.64B in revenue (up 15% YoY).

Trending AI Robots

One tool I find useful for navigating these markets is Tickeron’s Trending AI Robots page, which highlights the top 25 performers from a library of over 350 AI trading bots. These bots trade thousands of tickers across stocks, ETFs, and crypto using strategies like trend-following, mean reversion, momentum swings, and multi-agent portfolios with take-profit/stop-loss corridors, on timeframes from 5 minutes to 60 days. They're selected based on risk-adjusted metrics for current conditions, with top ones showing annualized returns of +23% to +289%, win rates of 50-88%, profit factors up to 11.7, and Sharpe ratios often above 1.5. Drawdowns are typically under 15% in backtests and forward tests. For instance, there's a semiconductor manufacturing bot (covering LRCX, TER, AMAT, etc.) at +97% return and 64% win rate, plus others tied to AI infrastructure like data storage. I check these periodically to refine my approach in volatile environments.

2026 Outlook and What I'm Watching

Looking ahead through 2026, I think execution on the 1touch integration will be crucial for Everpure to deliver a unified data platform that powers AI data pipelines amid rising enterprise demand. Subscription ARR, expected to grow 15-20% or more, is a key driver, with RPO providing visibility into sustained hyperscale and modernization bookings. FY2027 revenue guidance of about $3.64B (14-15% growth) and non-GAAP margins targeting over 20% depend on flash array adoption for hot AI data tiers, tempered by component cost swings.

Broader trends like AI infrastructure buildouts favor all-flash storage over legacy options, but competition from Dell, NetApp, and cloud natives is heating up. Post-1touch, keep an eye on regulatory aspects around data privacy and security, as well as partner ecosystem growth in cyber resilience and cloud. Macro risks include potential capex pullbacks if AI ROI falls short, or supply chain issues. On the upside, greater Enterprise Data Cloud adoption could bring hyperscaler wins similar to Meta deals. I'm watching Q1 FY2027 results closely for updates on guidance, bookings, and margins—these will help confirm the transition from storage pure-play to data orchestrator. I also checked this using Tickeron’s AI Screener to compare PSTG against industry peers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: PSTG
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of flash-based storage solutions

Industry ComputerProcessingHardware

Industry
Computer Peripherals
Address
2555 Augustine Drive
Phone
+1 800 379-7873
Employees
5600
Web
https://www.purestorage.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.